Does the extend of the culture time of primary hepatocytes in a bioreactor affect the treatment efficacy of a bioartificial liver?

International Journal of Artificial Organs

Volumn 21, Issue 9, 1998, Pages 542-547

  Flendrig, L M ^a,b   Maas, M A W ^a   Daalhuisen, J ^a   Ladiges, N C J J ^a   La Soe, J W ^a   Te Velde, A A ^a   Chamuleau, R A F M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Alpha GST; Bioartificial liver; Bioreactor; Hepatocytes; Liver ischemia; Liver support

Indexed keywords

AMMONIA; BIOCONVERSION; BIOREACTORS; RATS;

ALPHA-GST; BIOARTIFICIAL LIVER; BIOREACTOR; CULTURE TIME; HEPATIC ENCEPHALOPATHIES; HEPATOCYTES; LIVER ISCHEMIA; LIVER SUPPORT; PRIMARY HEPATOCYTES; STATISTICALLY SIGNIFICANT DIFFERENCE;

ARTIFICIAL ORGANS;

AMMONIA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; BIOREACTOR; COMA; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; LIVER CELL CULTURE; LIVER ISCHEMIA; MALE; NONHUMAN; RAT; SURVIVAL; SWINE;

EID: 0031758927     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jauregui HO, Mullon CJ-P, Trenkler D, et al. In vivo evaluation of a hollow fiber liver assist device. Hepatology 1995; 21: 460-9.
2. Sielaff TD, Hu MY, Amiot B, et al. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 1995; 59: 179-84.
3. Uchino J, Tsuburya T, Kumagai F, et al. A hybrid artificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans 1988; 34: 972-7.
4. Takahashi M, Matsue H, Matsushita M, et al. Does a porcine hepatocyte hybrid artificial liver prolong the survival time of anhepatic rabbits? ASAIO J 1992: M468-72.
5. Flendrig LM, te Velde AA, Chamuleau RAFM. Semipermeable hollow-fiber membranes in hepatocyte bioreactors: A prerequisite for a successful bioartificial liver? Int J Artif Organs 1997; 21: 1177-81.
6. Flendrig LM., Di Florio E, Mancini A et al. In vivo evaluation of a novel bioartificial liver in a surgical model of acute liver failure in the pig. Preliminary results. In: Crepaldi G, Demetriou AA, Muraca M. Bioartificial liver support systems. The critical issues. Rome: CIC Edizioni Internazionali, 1997: 42-7.
7. Flendrig LM, La Soe JW, Jörning GG, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound non-woven polyester matrix for hepatocyte cul-ture as small aggregates. J Hepatology 1997; 26: 1379-92.
8. te Velde AA, Ladiges NCJJ, Flendrig LM, Chamuleau RAFM. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implications for application of pig hepatocytes in a bioaritificial liver. J Hepatol 1995; 23: 184-92.
9. te Velde AA, Flendrig LM, Ladiges NCJJ, Chamuleau RAFM. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute hepatic failure, Int J Artif Organs 1997; 20: 229-33.
10. te Velde AA, Flendrig LM, Ladiges NCJJ, Chamuleau RAFM. Possible immunological problems of bioartificial liver support. Int J Artif Organs 1997; 20: 418-21.
11. Lee SH, Fischer B. Portacaval shunt in the rat. Surgery 1961; 50: 668-72.
12. Trull AK, Facey SP, Rees GW, et al. Serum α-glutathione S-transferase: A sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation 1994; 58: 1345-51
13. Watanabe FD, Mullon C J-P, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 1997; 225: 484-94.
14. Gerlach JC. Development of a hybrid liver support system: a review. Int J Artif Organs 1996; 19: 645-54.